Primary analysis of EPIK-O/ENGOT-ov61: alpelisib plus olaparib versus chemotherapy in platinum-resistant or platinum-refractory high-grade serous ovarian cancer without BRCA mutation - Konstantinopoulos, Panagiotis A.; Kim, Jae Weon; Freyer, Gilles; Lee, Jung Yun; Gaba, Lydia; Grisham, Rachel N.; Colombo, Nicoletta; Wu, Xiaohua; Sehouli, Jalid; Cruz, Felipe; Cibula, David; Monk, Bradley J.; et al. (Journal of clinical oncology, 2025)
Online veröffentlicht: 23. Juli, 2025